Advertisement

Topics

Pharmaxis, Inc. Company Profile

03:06 EDT 21st September 2017 | BioPortfolio


News Articles [12 Associated News Articles listed on BioPortfolio]

Pharmaxis to get milestone from Boehringer deal

Australia’s Pharmaxis has announced that it now expects to receive milestones from its collaboration…

Boehringer Ingelheim Liver Disease Study Begins Next Phase

NewsBoehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH. Pharmaxis will receive an 18 million euro milestone payment.

Boehringer Ingelheim Liver Disease Study Begins Phase II

NewsBoehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH. Pharmaxis will receive an 18 million euro milestone payment.

Boehringer Ingelheim initiates phase IIa study of liver disease NASH compound

Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has initiated a European and North American phase IIa trial in NASH with BI 1467335 (formerly known as PX...

Pharmaxis Boehringer Ingelheim Is Initiating Phase Iia Study For The Development Of A New Treatment For Diabetic Retinopathy - A Leading Cause Of Vision-Loss

  Life Sciences Jobs   ...

Synairgen to examine the potential for inhaled interferon beta in COPD

Respiratory drug discovery and development company Synairgen plc (LON:SNG) remains on track to advance a Pharmaxis compound into Phase I trials this year. In its full-year results for 2016...

Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH

Boehringer Ingelheim commences Phase II program of investigational drug candidate BI 1467335 acquired from Pharmaxis with a 12 week Phase IIa proof of clinical principle study in non-alcoholic s...

Pharmaxis Ltd PXS Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryPharmaxis Ltd Pharmaxis is a research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Aridol bronchial challenge test kit [Pharmaxis Ltd]

These highlights do not include all the information needed to use ARIDOL safely and effectively. See full prescribing information for ARIDOL. ARIDOL™ (mannitol inhalation powder) Bronchial Challenge...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Pharmaxis Ltd

Pharmaxis (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory diso...

Pharmaxis

Pharmaxis Ltd is a specialist pharmaceutical company established to research, development and bring to market human therapeutic products to treat chronic respiratory and autoimmune diseases. Founded ...

Pharmaxis Ltd.

Pharmaxis, Inc.

More Information about "Pharmaxis, Inc." on BioPortfolio

We have published hundreds of Pharmaxis, Inc. news stories on BioPortfolio along with dozens of Pharmaxis, Inc. Clinical Trials and PubMed Articles about Pharmaxis, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaxis, Inc. Companies in our database. You can also find out about relevant Pharmaxis, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record